Conclusion

The Revised Authoritative Guide To Vaccine Legal Exemptions

Vaccines Have Serious Side Effects

Get Instant Access

The most prevalent intestinal parasites associated with morbidity in children are the protozoa Cryptosporidium, Giardia and Entameoba histolytica, and the helminths Trichuris, Ascaris, hookworm and Strongyloides. Although most infected children remain asymptomatic, some children with high intensity of infection have manifestations of severe and persistent enteropathy, particularly with strongyloidiasis, cryptosporidiosis, giardiasis and trichuriasis. In spite of reductions in overall child mortality rates over recent decades, intestinal parasites remain highly prevalent in children in the developing world with no evidence of decreases in either global prevalence or morbidity, despite effective treatment being available. Recent advances in molecular biology and immunology of parasites are improving diagnostic techniques and open the way for the development of vaccines to control them. New vaccines and mass chemotherapy programs appear to be more effective approaches in the control of intestinal parasites in the short-term than improvements in hygiene, sanitation and living standards.

REFERENCES

Booth M, Bundy DA, Albonico M et al. Associations among multiple geohelminth species infections in schoolchildren from Pemba Island. Parasitology 1998; 116: 85-93.

Anonymous. Prevention and Control of Schistosomiasis and Soil-Transmitted Helminthiasis. WHO Technical Report Series 912. Geneva: World Health Organization. 2002: 1-57.

Yu SH, Xu LQ, Jiang ZX et al. Nationwide survey of human parasite in China. Southeast Asian J Trop Med Public Health 1994; 25: 4-10.

Brooker S, Rowlands M, Haller L et al. Towards an atlas of human helminth infection in sub-Saharan Africa: the use of geographical information systems (GIS). Parasitol Today 2000; 16: 303-307.

  1. The Partnership for Child Development. The health and nutritional status of schoolchildren in Africa: evidence from school-based health programmes in Ghana and Tanzania. Trans R Soc Trop Med Hyg 1998; 92: 254-261.
  2. Amin OM. Seasonal prevalence of intestinal parasites in the United States during 2000. Am J Trop Med Hyg 2002; 66: 799-803.
  3. Booth M, Mayombana C, Machibya H et al. The use of morbidity questionnaires to identify communities with high prevalences of schistosome or geohelminth infections in Tanzania. Trans R Soc Trop Med Hyg 1998; 92: 484-490.
  4. Tshikuka JG, Gray DK, Scott M, Olela KN. Relationship of childhood protein-energy malnutrition and parasite infections in an urban African setting. Trop Med Int Health 1997; 2: 374-382.
  5. Genta RM. Diarrhea in helminthic infections. Clin Infect Dis 1993; 16(Suppl 2): S122-S129.
  6. Kukuruzovic RH, Robins Browne RM, Anstey N, Brewster DR. Enteric pathogens, intestinal permeability and nitric oxide production in childhood diarrheal disease. Pediatr Infect Dis J 2002; 21: 730-739.
  7. Gillin FD, Reiner DS, Gault MJ et al. Encystation and expression of cyst antigens by Giardia lamblia in vitro. Science 1987; 235: 1040-1043.
  8. Lujan HD, Mowatt MR, Byrd LG, Nash TE. Cholesterol starvation induces differentiation of the intestinal parasite Giardia lamblia. Proc Natl Acad Sci USA 1996; 93: 7628-7633.
  9. Touz MC, Nores MJ, Slavin I et al. Membrane-associated dipeptidyl peptidase IV is involved in encystation-specific gene expression during Giardia differentiation. Biochem J 2002; 364: 703-710.
  10. Thompson SC. Giardia lamblia in children and the child care setting: a review of the literature. J Paediatr Child Health 1994; 30: 202-209.
  11. Nuchprayoon S, Siriyasatien P, Kraivichian K et al. Prevalence of parasitic infections among Thai patients at the King Chulalongkorn Memorial Hospital, Bangkok, Thailand. J Med Assoc Thai 2002; 85 (Suppl 1): S415-S423.
  12. Molbak K, Wested N, Hojlyng N et al. The etiology of early childhood diarrhea: a community study from Guinea-Bissau. J Infect Dis 1994; 169: 581-587.
  13. Newman RD, Moore SR, Lima AA et al. A longitudinal study of Giardia lamblia infection in north-east Brazilian children. Trop Med Int Health 2001; 6: 624-634.
  14. Mahmud MA, Chappell CL, Hossain MM et al. Impact of breast-feeding on Giardia lamblia infections in Bilbeis, Egypt. Am J Trop Med Hyg 2001; 65: 257-260.
  15. Chunge RN, Nagelkerke N, Karumba PN et al. Longitudinal study of young children in Kenya: intestinal parasitic infection with special reference to Giardia lamblia, its prevalence, incidence and duration, and its association with diarrhoea and with other parasites. Acta Trop Basel 1991; 50: 39-49.
  16. Nain CK, Dutt P, Vinayak VK. Alterations in enzymatic activities of the intestinal mucosa during the course of Giardia lamblia infection in mice. Ann Trop Med Parasitol 1991; 85: 515-522.
  17. Buret AG, Mitchell K, Muench DG, Scott KG. Giardia lamblia disrupts tight junctional ZO-1 and increases permeability in non-transformed human small intestinal epithelial monolayers: effects of epidermal growth factor. Parasitology 2002; 125: 11-19.
  18. Hicks SJ, Theodoropoulos G, Carrington SD, Corfield AP. The role of mucins in host-parasite interactions. Part I. Protozoan parasites. Parasitol Today 2000; 16: 476-481.
  19. Pettoello MM, Guandalini S, Ecuba P et al. Lactose malabsorption in children with symptomatic Giardia lamblia infection: feasibility of yogurt supplementation. J Pediatr Gastroenterol Nutr 1989; 9: 295-300.
  20. Moya-Camarena SY, Sotelo N, Valencia ME. Effects of asymptomatic Giardia intestinalis infection on carbohydrate absorption in well-nourished Mexican children. Am J Trop Med Hyg 2002; 66: 255-259.
  21. Jove S, Fagundes-Neto U, Wehba J et al. Giardiasis in childhood and its effects on the small intestine. J Pediatr Gastroenterol Nutr 1983; 2: 472-7.
  22. Hjelt K, Paerregaard A, Krasilnikoff PA. Giardiasis: haematological status and the absorption of vitamin B12 and folic acid. Acta Paediatr 1992; 81: 29-34.
  23. Goto R, Panter-Brick C, Northrop-Clewes CA et al. Poor intestinal permeability in mildly stunted Nepali children: associations with weaning practices and Giardia lamblia infection. Br J Nutr 2002; 88: 141-149.
  24. Scott KG, Meddings JB, Kirk DR et al. Intestinal infection with Giardia spp. reduces epithelial barrier function in a myosin light chain kinase-dependent fashion. Gastroenterology 2002; 123: 1179-1190.
  25. Roberts Thomson IC, Mitchell GF, Anders RF et al. Genetic studies in human and murine giardiasis. Gut 1980; 21: 397-401.
  26. Char S, Cevallos AM, Yamson P et al. Impaired IgA response to Giardia heat shock antigen in children with persistent diarrhoea and giardiasis. Gut 1993; 34: 38-40.
  27. Walterspiel JN, Morrow AL, Lourdes Guerrero M et al. Secretory anti-Giardia lamblia antibodies in human milk: protective effect against diarrhea. Pediatrics 1994; 93: 28-31.
  28. Di Prisco MC, Hagel I, Lynch NR et al. Association between giardiasis and allergy. Ann Allergy Asthma Immunol 1998; 81: 261-265.
  29. Cevallos AM, Carnaby S, James M, Farthing MJ. Small intestinal injury in a neonatal rat model of giardiasis is strain dependent. Gastroenterology 2002; 109: 766-773.
  30. Jimenez JC, Rodriguez N, Di Prisco MC et al. Haemoglobin concentrations and infection by Giardia intestinalis in children: effect of treatment with secnidazole. Ann Trop Med Parasitol 1999; 93: 823-827.
  31. Lane S, Lloyd D. Current trends in research into the waterborne parasite Giardia. Crit Rev Microbiol 2002; 28: 123-147.
  32. Matsuyama W, Mizoguchi A, Iwami F et al. [A case of pulmonary infiltration with eosinophilia caused by Ascaris suum]. Nihon Kokyuki Gakkai Zasshi 1998; 36: 208-12.
  33. de Silva NR, Chan MS, Bundy DA. Morbidity and mortality due to ascariasis: re-estimation and sensitivity analysis of global numbers at risk. Trop Med Int Health 1997; 2: 519-528.
  34. Hall A, Holland C. Geographical variation in Ascaris lumbricoides fecundity and its implications for helminth control. Parasitol Today 2000; 16: 540-544.
  35. Geissler PW, Mwaniki D, Thiong F, Friis H. Geophagy as a risk factor for geohelminth infections: a longitudinal study of Kenyan primary schoolchildren. Trans R Soc Trop Med Hyg 1998; 92: 7-11.
  36. Saathoff E, Olsen A, Kvalsvig JD, Geissler PW. Geophagy and its associates with geohelminth infection in rural schoolchildren from northern KwaZulu-Natal, South Africa. Trans R Soc Trop Med Hyg 2002; 96: 485-90.
  37. Muller R. Worms and Human Disease. 2nd edn. Wallingford, UK: CABI Publishing, 2002.
  38. Kennedy MW. The nematode polyprotein allergens/ antigens. Parasitol Today 2000; 16: 373-380.
  39. Viney M. How do host immune responses affect nematode infections? Trends Parasitol 2002; 18: 63-66.
  40. Scott ME, Koski KG. Zinc deficiency impairs immune responses against parasitic nematode infections at intestinal and systemic sites. J Nutr 2000; 130: 1412S-1420S.
  41. Cooper PJ, Chico M, Sandoval C et al. Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR. Infect Immun 2001; 69: 1574-1580.

Cooper PJ, Chico ME, Losonsky G et al. Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR. J Infect Dis 2000; 182: 1199-1206.

Wolday D, Mayaan S, Mariam ZG et al. Treatment of intestinal worms is associated with decreased HIV plasma viral load. JAcquir Immune Defic Syndr 2002; 31: 56-62.

Cooper PJ, Chico ME, Sandoval C et al. Human infection with Ascaris lumbricoides is associated with a polarized cytokine response. J Infect Dis 2000; 182: 1207-1213.

Behm CA,.Ovington KS. The role of eosinophils in parasitic helminth infections: insights from genetically modified mice. Parasitol Today 2000; 16: 202-209. Meeusen EN, Balic A. Do eosinophils have a role in the killing of helminth parasites? Parasitol Today 2000; 16: 95-101.

Lynch NR, Hagel I, Perez M et al. Effect of anthelmintic treatment on the allergic reactivity of children in a tropical slum. J Allergy Clin Immunol 1993; 92: 404-411. Perzanowski MS, Ng'ang'a LW, Carter MC et al. Atopy, asthma, and antibodies to Ascaris among rural and urban children in Kenya. J Pediatr 2002; 140: 582-588. Lynch NR, Hagel IA, Palenque ME et al. Relationship between helminthic infection and IgE response in atopic and nonatopic children in a tropical environment. J Allergy Clin Immunol 1998; 101: 217-221.

Gendrel D, Richard Lenoble D, Kombila M et al. Influence of intestinal parasitism on lactose absorption in well-nourished African children. Am J Trop Med Hyg 1992; 46: 137-140.

Raj SM, Sein KT, Anuar AK, Mustaffa BE. Effect of intestinal helminthiasis on intestinal permeability of early primary schoolchildren. Trans R Soc Trop Med Hyg 1996; 90: 666-669.

Chitkara RK, Sarinas PS. Dirofilaria, visceral larva migrans, and tropical pulmonary eosinophilia. Semin Respir Infect 1997; 12: 138-148. de Silva NR, Guyatt HL, Bundy DA. Morbidity and mortality due to Ascaris-induced intestinal obstruction. Trans R Soc Trop Med Hyg 1997; 91: 31-36. Carneiro FF, Cifuentes E, Tellez-Rojo MM, Romieu I. The risk of Ascaris lumbricoides infection in children as an environmental health indicator to guide preventative activities in Caparao and Alto Caparo, Brazil. Bull World Health Organ 2002; 80: 40-46.

Olsen A, Samuelsen H, Onyango-Ouma W. A study of risk factors for intestinal helminth infections using epidemiological and anthropological approaches. J Biosoc Sci 2001; 33: 569-584.

Adenusi AA. The distribution of Necator americanus and Ancylostoma duodenale among schoolchildren in Lagos, Nigeria. Trans R Soc Trop Med Hyg 1997; 91: 270. Walker NI, Croese J, Clouston AD et al. Eosinophilic enteritis in northeastern Australia. Pathology, association with Ancylostoma caninum, and implications. Am J Surg Pathol 1995; 19: 328-37. Sen L, Ghosh K, Bin Z et al. Hookworm burden reductions in BALB/c mice vaccinated with recombinant Ancylostoma secreted proteins (ASPs) from Ancylostoma duodenale, Ancylostoma caninum and Necator americanus. Vaccine 2000; 18: 1096-1102. Yu SH, Jiang ZX, Xu LQ. Infantile hookworm disease in China. A review. Acta Trop 1995; 59: 265-270. Albonico M, Smith PG, Ercole E et al. Rate of reinfection with intestinal nematodes after treatment of children with mebendazole or albendazole in a highly endemic area. Trans R Soc Trop Med Hyg 1995; 89: 538-541.

  1. Olsen A, Nawiri J, Friis H. The impact of iron supplementation on reinfection with intestinal helminths and Schistosoma mansoni in western Kenya. Trans R Soc Trop Med Hyg 2000; 94: 493-499.
  2. Guyatt HL, Brooker S, Kihamia CM et al. Evaluation of efficacy of school-based anthelmintic treatments against anemia in children in the United Republic of Tanzania. Bull World Health Organ 2001; 79: 695-703.
  3. Beasley NM, Tomkins AM, Hall A et al. The impact of population level deworming on the haemoglobin levels of schoolchildren in Tanga, Tanzania. Trop Med Int Health 1999; 4: 744-750.
  4. Stephenson LS, Holland CV, Cooper ES. The public health significance of Trichuris trichiura. Parasitology 2000; 121 (Suppl): S73-S95.
  5. Brown CJ, McCloskey DJ, Bundy DA, Navarrete CV. Parasitic infection with Trichuris trichiura influences plasma levels of soluble HLA class I. Hum Immunol 1999; 60: 1067-1071.
  6. Needham C, Kim HT, Hoa NV et al. Epidemiology of soil-transmitted nematode infections in Ha Nam Province, Vietnam. Trop Med Int Health 1998; 3: 904-912.
  7. MacDonald TT, Choy MY, Spencer J et al. Histopathology and immunohistochemistry of the caecum in children with the Trichuris dysentery syndrome. J Clin Pathol 1991; 44: 194-199.
  8. Cooper ES, Whyte Alleng CA, Finzi Smith JS et al. Intestinal nematode infections in children: the pathophysiological price paid. Parasitology 1992; 104 (Suppl): S91-103.
  9. Cooper ES, Ramdath DD, Whyte Alleng C et al. Plasma proteins in children with Trichuris dysentery syndrome. J Clin Pathol 1997; 50: 236-240.
  10. Duff EM, Anderson NM, Cooper ES. Plasma insulin-like growth factor-1, type 1 procollagen, and serum tumor necrosis factor alpha in children recovering from Trichuris dysentery syndrome. Pediatrics 1999; 103: e69.
  11. MacDonald TT, Spencer J, Murch SH et al. Immunoepidemiology of intestinal helminthic infections. 3. Mucosal macrophages and cytokine production in the colon of children with Trichuris trichiura dysentery. Trans R Soc Trop Med Hyg 1994; 88: 265-268.
  12. Cooper ES, Spencer J, Whyte-Alleng CA et al. Immediate hypersensitivity in colon of children with chronic Trichuris trichiura dysentery. Lancet 1991; 338: 1104-1107.
  13. Raj SM. Fecal occult blood testing on Trichuris-infected primary school children in northeastern peninsular Malaysia. Am J Trop Med Hyg 1999; 60: 165-166.
  14. Kaur G, Raj SM, Naing NN. Trichuriasis: localized inflammatory responses in the colon. Southeast Asian J Trop Med Public Health 2002; 33: 224-228.
  15. Kamath KR. Severe infection with Trichuris trichiura in Malaysian children. A clinical study of 30 cases treated with stilbazium iodine. Am J Trop Med Hyg 1973; 22: 600-605.
  16. Mathan VI,.Baker SJ. Whipworm disease. Intestinal structure and function of patients with severe Trichuris trichuria infestation. Am J Dig Dis 1970; 15: 913-918.
  17. Gilman RH, Davis C, Fitzgerald F. Heavy Trichuris infection and amoebic dysentery in Orang Asli children. A comparison of the two diseases. Trans R Soc Trop Med Hyg 1976; 70: 313-316.
  18. Noorizan AM, Mahendra RS. Trichuris dysentery syndrome: evidence that it may be underdiagnosed in Kelantan. Med J Malaysia 2001; 56: 53-57.
  19. Phillips AD, Thomas AG, Walker-Smith JA. Cryptosporidium, chronic diarrhea and the proximal small intestinal mucosa. Gut 1992; 33: 1057-1061.
  20. Bern C, Ortega Y, Checkley W et al. Epidemiologic differences between cyclosporiasis and cryptosporidiosis in Peruvian children. Emerg Infect Dis 2002; 8: 581-585.
  21. Nchito M, Kelly P, Sianongo S et al. Cryptosporidiosis in urban Zambian children: an analysis of risk factors. Am J Trop Med Hyg 1998; 59: 435-437.
  22. Molbak K, Hojlyng N, Ingholt L et al. An epidemic outbreak of cryptosporidiosis: a prospective community study from Guinea Bissau. Pediatr Infect Dis J 1990; 9: 566-570.
  23. Molbak K, Aaby P, Hojilyng N, Da Silva APJ. Risk factors for Cryptosporidium diarrhea in early childhood: a case-control study from Guinea-Bissau, West Africa. Am J Epidemiol 1994; 139: 734-740.
  24. Molbak K, Hojlyng N, Gottschau A et al. Cryptosporidiosis in infancy and childhood mortality in Guinea Bissau, west Africa. Br Med J 1993; 307: 417-420.
  25. Molbak K, Lisse IM, Hojlyng N, Aaby P. Severe cryptosporidiosis in children with normal T-cell subsets. Parasite Immunol 1994; 16: 275-277.
  26. Iqbal J, Hira PR, Al Ali F, Philip R. Cryptosporidiosis in Kuwaiti children: seasonality and endemicity. Clin Microbiol Infect 2001; 7: 261-266.
  27. Adegbola RA, Demba E, De Veer G, Todd J. Cryptosporidium infection in Gambian children less than 5 years of age. J Trop Med Hyg 1994; 97: 103-107.
  28. Javier Enriquez F, Avila CR, Ignacio Santos J et al. Cryptosporidium infections in Mexican children: clinical, nutritional, enteropathogenic, and diagnostic evaluations. Am J Trop Med Hyg 1997; 56: 254-257.
  29. Agnew DG, Lima AA, Newman RD et al. Cryptosporidiosis in northeastern Brazilian children: association with increased diarrhea morbidity. J Infect Dis 1998; 177: 754-760.
  30. McDonald AC, MacKenzie WR, Addiss DG et al. Cryptosporidium parvum-specific antibody responses among children residing in Milwaukee during the 1993 waterborne outbreak. J Infect Dis 2001; 183: 1373-1379.
  31. Cicirello HG, Kehl KS, Addiss DG et al. Cryptosporidiosis in children during a massive waterborne outbreak in Milwaukee, Wisconsin: clinical, laboratory and epidemiologic findings. Epidemiol Infect 1997; 119: 53-60.
  32. Cordell RL, Thor PM, Addiss DG et al. Impact of a massive waterborne cryptosporidiosis outbreak on child care facilities in metropolitan Milwaukee, Wisconsin. Pediatr Infect Dis J 1997; 16: 639-644.
  33. Moore R, Tzipori S, Griffiths JK et al. Temporal changes in permeability and structure of piglet ileum after site-specific infection by Cryptosporidium parvum. Gastroenterology 1995; 108: 1030-1039.
  34. Capet C, Kapel N, Huneau JF et al. Cryptosporidium parvum infection in suckling rats: impairment of mucosal permeability and Na(+)-glucose cotransport. Exp Parasitol 1999; 91: 119-125.
  35. Wyatt CR, Brackett EJ, Savidge J. Evidence for the emergence of a type-1-like immune response in intestinal mucosa of calves recovering from cryptosporidiosis. J Parasitol 2001; 87: 90-95.
  36. Pollok RC, Farthing MJ, Bajaj-Elliott M et al. Interferon gamma induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum. Gastroenterology 2001; 120: 99-107.
  37. Hayward AR, Chmura K, Cosyns M. Interferon-gamma is required for innate immunity to Cryptosporidium parvum in mice. J Infect Dis 2000; 182: 1001-1004.
  38. Lawrence CE, Paterson JC, Higgins LM et al. IL-4-regulated enteropathy in an intestinal nematode infection. Eur J Immunol 1998; 28: 2672-2684.
  39. Garside P, Kennedy MW, Wakelin D, Lawrence CE. Immunopathology of intestinal helminth infection. Parasite Immunol 2000; 22: 605-612.
  40. Leitch GJ, He Q. Reactive nitrogen and oxygen species ameliorate experimental cryptosporidiosis in the neonatal BALB/c mouse model. Infect Immun 1999; 67: 5885-5891.
  41. Leitch GJ, He Q. Arginine-derived nitric oxide reduces fecal oocyst shedding in nude mice infected with Cryptosporidium parvum. Infect Immun 1994; 62: 5173-5176.
  42. Goodgame RW, Kimball K, Ou CN et al. Intestinal function and injury in acquired immunodeficiency syndrome-related cryptosporidiosis. Gastroenterology 1995; 108: 1075-1082.
  43. Checkley W, Epstein LD, Gilman RH et al. Effects of Cryptosporidium parvum infection in Peruvian children: growth faltering and subsequent catch-up growth. Am J Epidemiol 1998; 148: 497-506.
  44. Molbak K, Andersen M, Aaby P et al. Cryptosporidium infection in infancy as a cause of malnutrition: a community study from Guinea-Bissau, West Africa. Am J Clin Nutr 1997; 65: 149-152.
  45. Guarino A, Castaldo A, Russo S et al. Enteric cryptosporidiosis in pediatric HIV infection. J Pediatr Gastroenterol Nutr 1997; 25: 182-187.
  46. Sarabia Arce S, Salazar Lindo E, Gilman RH et al. Case-control study of Cryptosporidium parvum infection in Peruvian children hospitalized for diarrhea: possible association with malnutrition and nosocomial infection. Pediatr Infect Dis J 1990; 9: 627-631.
  47. Checkley W, Gilman RH, Epstein LD et al. Asymptomatic and symptomatic cryptosporidiosis: their acute effect on weight gain in Peruvian children. Am J Epidemiol 1997; 145: 156-163.
  48. Xiao L, Bern C, Limor J et al. Identification of 5 types of Cryptosporidium parasites in children in Lima, Peru. J Infect Dis 2001; 183: 492-497.
  49. Genta RM. Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease. Rev Infect Dis 1989; 11: 755-767.
  50. Egido JM, De Diego JA, Penin P. The prevalence of enteropathy due to strongyloidiasis in Puerto Maldonado (Peruvian Amazon). Braz J Infect Dis 2001; 5: 119-123.
  51. Clyne M, Labigne A, Drumm B. Helicobacter pylori requires an acidic environment to survive in the presence of urea. Infect Immun 1995; 63: 1669-1673.
  52. Quiros A, Quiros E, Gonzalez I et al. Helicobacter pylori seroepidemiology in risk groups. Eur J Epidemiol 1994; 10: 299-301.
  53. Barnish G, Ashford RW. Strongyloides cf. fuelleborni and hookworm in Papua New Guinea: patterns of infection within the community. Trans R Soc Trop Med Hyg 1989; 83: 684-688.
  54. Milner PF, Irvine RA, Barton CJ et al. Intestinal malabsorption in Strongyloides stercoralis infestation. Gut 1965; 6: 574-581.
  55. Sipahi AM, Damiao AO, Simionato CS et al. Small bowel bacterial overgrowth in strongyloidiasis. Digestion 1991; 49: 120-124.
  56. Werneck-Silva AL, Sipahi AM, Damiao AO et al. Intestinal permeability in strongyloidiasis. Braz J Med Biol Res 2001; 34: 353-357.
  57. Sullivan PB, Lunn PG, Northrop Clewes CA, Farthing MJ. Parasitic infection of the gut and protein-losing enteropathy. J Pediatr Gastroenterol Nutr 1992; 15: 404-407.

Burke JA. Strongyloidiasis in childhood. Am J Dis Child 1978; 132: 1130-1136.

Atkins NS, Conway DJ, Lindo JF et al. L3 antigen-specific antibody isotype responses in human strongyloidiasis: correlations with larval output. Parasite Immunol 1999; 21: 517-526.

Walker AC, Blake G, Downing D. A syndrome of partial intestinal obstruction due to Strongyloides stercoralis. Med J Aust 1976; 1: 47-48.

Walker-Smith JA, McMillan B, Middleton AW et al. Strongyloidiasis causing small-bowel obstruction in an Aboriginal infant. Med J Aust 1969; 2: 1263-1265. Vince JD, Ashford RW, Gratten MJ, Bana-Koiri J. Strongyloides species infestation in young infants of Papua, New Guinea: association with generalized oedema. P N G Med J 1979; 22: 120-127. Barnish G, Barker J. An intervention study using thiabendazole suspension against Strongyloides fuelleborni-like infections in Papua New Guinea. Trans R Soc Trop Med Hyg 1987; 81: 60-63. Robinson RD, Lindo JF, Neva FA et al. Immunoepidemiologic studies of Strongyloides sterco-ralis and human T lymphotropic virus type I infections in Jamaica. J Infect Dis 1994; 169: 692-696. Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001; 33: 1040-1047.

Sato Y, Kobayashi J, Shiroma Y. Serodiagnosis of strongyloidiasis. The application and significance. Rev Inst Med Trop Sao Paulo 1995; 37: 35-41. Gyorkos TW, Genta RM, Viens P, MacLean JD. Seroepidemiology of Strongyloides infection in the Southeast Asian refugee population in Canada. Am J Epidemiol 1990; 132: 257-264. Haque R, Faruque AS, Hahn P et al. Entamoeba histolytica and Entamoeba dispar infection in children in Bangladesh. J Infect Dis 1997; 175: 734-736. Heckendorn F, N'Goran EK, Felger I et al. Species-specific field testing of Entamoeba spp. On an area of high endemicy. Trans R Soc Trop Med Hyg 2002; 96: 521-528.

Braga LL, Gomes ML, Da Silva MW et al. Household epidemiology of Entamoeba histolytica infection in an urban community in northeastern Brazil. Am J Trop Med Hyg 2001; 65: 268-271.

Stanley SL. Pathophysiology of amoebiasis. Trends Parasitol 2001; 17: 280-285.

Haque R, Duggal P, Ali IM et al. Innate and acquired resistance to amebiasis in Bangladeshi children. J Infect Dis 2002; 186: 547-552.

Haque R, Ali IM, Petri WA Jr. Prevalence and immune response to Entamoeba histolytica infection in preschool children in Bangladesh. Am J Trop Med Hyg 1999; 60: 1031-1034.

Ayeh-Kumi PF, Ali IM, Lockhart LA et al. Entamoeba histolytica: genetic diversity of clinical isolates from Bangladesh as demonstrated by polymorphisms in the serine-rich gene. Exp Parasitol 2001; 99: 80-88. Sirivichayakul C, Radomyos P, Praevanit R et al. Hymenolepis nana infection in Thai children. J Med Assoc Thai 2000; 83: 1035-1038. Liu LX, Chi J, Upton MP, Ash LR. Eosinophilic colitis associated with larvae of the pinworm Enterobius vermicularis. Lancet 1995; 346: 410-412. Sinniah B, Leopairut J, Neafie RC et al. Enterobiasis: a histopathological study of 259 patients. Ann Trop Med Parasitol 1991; 85: 625-635.

  1. Hoge CW, Shlim DR, Rajah R et al. Epidemiology of diarrheal illness associated with coccidian-like organism among travellers and foreign residents in Nepal. Lancet 1993; 341: 1175-1179.
  2. Ho AY, Lopez AS, Eberhart MG et al. Outbreak of cyclosporiasis associated with imported raspberries, Philadelphia, Pennsylvania, 2000. Emerg Infect Dis 2002; 8: 783-788.
  3. Katz D, Kumar S, Malecki J et al. Cyclosporiasis associated with imported raspberries, Florida, 1996. Public Health Rep 1999; 114: 427-438.
  4. Quintero-Betancourt W, Peele ER, Rose JB. Cryptosporidium parvum and Cyclospora cayetanensis: a review of laboratory methods for detection of these waterborne parasites. J Microbiol Methods 2002; 49: 209-224.
  5. Bern C, Hernandez B, Lopez MB et al. The contrasting epidemiology of Cyclospora and Cryptosporidium among outpatients in Guatemala. Am J Trop Med Hyg 2000; 63: 231-235.
  6. Eberhard ML, Nace EK, Freeman AR et al. Cyclospora cayetanensis infections in Haiti: a common occurrence in the absence of watery diarrhea. Am J Trop Med Hyg 1999; 60: 584-586.
  7. Chacin-Bonilla L, Estevez J, Monsalve F, Quijada L. Cyclospora cayetanensis infections among diarrheal patients from Venezuela. Am J Trop Med Hyg 2001; 65: 351-354.
  8. Pape JW, Verdier RI, Boncy M et al. Cyclospora infection in adults infected with HIV. Clinical manifestations, treatment, and prophylaxis. Ann Intern Med 1994; 121: 654-657.
  9. Connor BA, Shlim DR, Scholes JV et al. Pathologic changes in the small bowel in nine patients with diarrhea associated with a coccidia-like body. Ann Intern Med 1993; 119: 377-382.
  10. Rigo CR,.Franco RM. [Comparison between the modified Ziehl-Neelsen and acid-fast-trichrome methods for fecal screening of Cryptosporidium parvum and Isospora belli]. Rev Soc Bras Med Trop 2002; 35: 209-214.
  11. Sherchand JB,.Cross JH. Emerging pathogen Cyclospora cayetanensis infection in Nepal. Southeast Asian J Trop Med Public Health 2001; 32 (Suppl 2): 143-150.
  12. Rizk H, Soliman M. Coccidiosis among malnourished children in Mansoura, Dakahlia Governorate, Egypt. J Egypt Soc Parasitol 2001; 31: 877-886.
  13. Madico G, McDonald J, Gilman RH et al. Epidemiology and treatment of Cyclospora cayetanensis infection in Peruvian children. Clin Infect Dis 1997; 24: 977-981.
  14. Hoge CW, Shlim DR, Ghimire M et al. Placebo-controlled trial of co-trimoxazole for Cyclospora infections among travellers and foreign residents in Nepal. Lancet 1995; 345: 691-693.
  15. Horton J. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitology 2000; 121 (Suppl): S113-S132.
  16. Forrester JE, Bailar JC III, Esrey SA et al. Randomised trial of albendazole and pyrantel in symptomless trichuriasis in children. Lancet 1998; 352: 1103-1108.
  17. Montresor A, Stoltzfus RJ, Albonico M et al. Is the exclusion of children under 24 months from anthelmintic treatment justifiable? Trans R Soc Trop Med Hyg 2002; 96: 197-199.
  18. Zulu I, Veitch A, Sianongo S et al. Albendazole chemotherapy for AIDS-related diarrhea in Zambia -clinical, parasitological and mucosal responses. Aliment Pharmacol Ther 2002; 16: 595-601.
  19. Belizario VY, Amarillo ME, de Leon WU et al. A comparison of the efficacy of single doses of albendazole, ivermectin, and diethylcarbamzine alone or in combinations against Ascaris and Trichuris spp. Bull World Health Organ 2003; 81: 35-42.
  20. Hall A, Nahar Q. Albendazole as a treatment for infections with Giardia duodenalis in children in Bangladesh. Trans R Soc Trop Med Hyg 1993; 87: 84-86.
  21. Ermis B, Aslan T, Beder L, Unalacak M. A randomized placebo-controlled trial of mebendazole for halitosis. Arch Pediatr Adolesc Med 2002; 156: 995-998.
  22. Marti H, Haji HJ, Savioli L et al. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am J Trop Med Hyg 1996; 55: 477-481.
  23. Behnke JM, Pritchard DI, Wakelin D et al. Effect of ivermectin on infection with gastro-intestinal nematodes in Sierra Leone. J Helminthol 1994; 68: 187-195.
  24. Datry A, Hilmarsdottir I, Mayorga Sagastume R et al. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases. Trans R Soc Trop Med Hyg 1994; 88: 344-345.
  25. Gann PH, Neva FA, Gam AA. A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis 1994; 169: 1076-1079.
  26. Misra PK, Kumar A, Agarwal V, Jagota SC. A comparative clinical trial of albendazole versus metronidazole in children with giardiasis. Indian Pediatr 1995; 32: 779-782.
  27. Lares Asseff I, Cravioto J, Santiago P, Perez Ortiz B. A new dosing regimen for metronidazole in malnourished children. Scand J Infect Dis 1993; 25: 115-121.
  28. Addiss DG, Juranek DD, Spencer HC. Treatment of children with asymptomatic and nondiarrheal Giardia infection. Pediatr Infect Dis J 1991; 10: 843-846.
  29. Ish Horowicz M, Korman SH, Shapiro M et al. Asymptomatic giardiasis in children. Pediatr Infect Dis J 1989; 8: 773-779.
  30. Pickering LK, Engelkirk PG. Giardia lamblia. Pediatr Clin North Am 1988; 35: 565-577.
  31. Zaat JO, Mank T, Assendelft WJ. Drugs for treating giardiasis. Cochrane Database Syst Rev 2000; CD000217.
  32. Gilles HM, Hoffman PS. Treatment of intestinal parasitic infections: a review of nitazoxanide. Trends Parasitol 2002; 18: 95-97.
  33. Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide. J Infect Dis 2001; 184: 381-384.
  34. Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide. J Infect Dis 2001; 184: 103-106.
  35. Davila-Gutierrez CE, Vasquez C, Trujillo-Hernandez B, Huerta M. Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children. Am J Trop Med Hyg 2002; 66: 251-254.
  36. Cedillo-Rivera R, Chavez B, Gonzalez-Robles A et al. In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites. J Eukaryot Microbiol 2002; 49: 201-208.
  37. Ortiz JJ, Chegne NL, Gargala G, Favennec L. Comparative clinical studies of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis and hymenolepiasis in children from Peru. Trans R Soc Trop Med Hyg 2002; 96: 193-196.
  38. Ortiz JJ, Ayoub A, Gargala G et al. Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru. Aliment Pharmacol Ther 2001; 15: 1409-1415.
  39. Amadi B, Mwiya M, Musuku J et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet 2002; 360: 1375-1380.
  40. Bissuel F, Cotte L, Rabodonirina M et al. Paromomycin: an effective treatment for cryptosporidial diarrhea in patients with AIDS. Clin Infect Dis 1994; 18: 447-449.
  41. Hewitt RG, Yiannoutsos CT, Higgs ES et al. Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group. Clin Infect Dis 2000; 31: 1084-1092.
  42. Anonymous. World Development Report 1993: Investing in Health. New York: Oxford University Press, 1993.
  43. World Health Organization. Guidelines for the Evaluation of Soil-transmitted Helminthiasis and Schistosomiasis at Community Level: a Guide for Managers of Control Programmes. Geneva: WHO, 1998.
  44. Brooker S, Marriot H, Hall A et al. Community perception of school-based delivery of anthelmintics in Ghana and Tanzania. Trop Med Int Health 2001; 6: 1075-1083.
  45. Allen HE, Crompton DW, de Silva N et al. New policies for using antihelmintics in high risk groups. Trends Parasitol 2002; 18: 381-382.
  46. Dickson R, Awasthi S, Williamson P et al. Effects of treatment for intestinal helminth infection on growth and cognitive performance in children: systematic review of randomised trials. Br Med J 2000; 320: 1697-1701.
  47. Dickson R, Awasthi S, Demellweek C, Williamson P. Anthelmintic drugs for treating worms in children: effects on growth and cognitive performance. Cochrane Database Syst Rev 2000; CD000371.
  48. Stoltzfus rJ, Kvalsvig JD, Chwaya HM et al. Effects of iron supplementation and anthelmintic treatment on motor and language development of preschool children in Zanzibar: double blind, placebo controlled study. Br Med J 2001; 323: 1389-1393.
  49. Olds GR, King C, Hewlett J et al. Double-blind placebo-controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geoheminths. J Infect Dis 1999; 179: 996-1003.
  50. Northrop-Clewes CA, Rousham EK, Mascie-Taylor CN, Lunn PG. Anthelmintic treatment of rural Bangladeshi children: effect on host physiology, growth, and biochemical status. Am J Clin Nutr 2001; 73: 53-60.
  51. Rousham EK. An increase in Giardia duodenalis infection among children receiving periodic anthelmintic treatment in Bangladesh. J Trop Pediatr 1994; 40: 329-333.
  52. Stettler N, Schutz Y, Jequier E. Effect of low-level pathogenic helminth infection on energy metabolism in Gambian children. Am J Trop Med Hyg 1998; 58: 476-479.
  53. Raj SM, Sein KT, Anuar AK, Mustaffa BE. Effect of intestinal helminthiasis on school attendance by early primary schoolchildren. Trans R Soc Trop Med Hyg 1997; 91: 131-132.
  54. Moore SR, Lima AA, Conaway MR et al. Early childhood diarrhea and helminthiases associated with long-term linear growth faltering. Int J Epidemiol 2001; 203

30: 1457-1464.

  1. Guyatt HL. Do intestinal nematodes affect productivity in adults? Parasitol Today 2000; 16: 153-158.
  2. Donnen P, Brasseur D, Dramaix M et al. Vitamin A supplementation but not deworming improves growth 204 of malnourished preschool children in eastern Zaire. J

Nutr 1998; 128: 1320-1327.

198. Taylor M, Jinabhai CC, Couper I et al. The effect of different anthelmintic treatment regimens combined 205

with iron supplementation on the nutritional status of schoolchildren in KwaZulu-Natal, South Africa: a randomized controlled trial. Trans R Soc Trop Med Hyg

2001; 95: 211-216. 206

  1. Muchiri EM, Thiong'o FW, Magnussen P, Ouma JH. A comparative study of different albendazole and mebendazole regimens for the treatment of intestinal infections in school children of Usigu Division, Western 207 Kenya. J Parasitol 2001; 87: 413-418.
  2. Albonico M, Renganathan E, Bosman A et al. Efficacy of a single dose of mebendazole on prevalence and intensity of soil-transmitted nematodes in Zanzibar. 208

Trop Geogr Med 1994; 46: 142-146.

201. Lunn PG, Erinoso HO, Northrop-Clewes CA, Boyce SA. Giardia intestinalis is unlikely to be a major cause of the poor growth of rural Gambian infants. J Nutr 1999; 129: 209

872-877.

202. Sullivan PB, Marsh MN, Phillips MB et al. Prevalence and treatment of giardiasis in chronic diarrhea and malnutrition. Arch Dis Child 1991; 66: 304-306.

Sullivan PS, DuPont HL, Arafat RR et al. Illness and reservoirs associated with Giardia lamblia infection in rural Egypt: the case against treatment in developing world environments of high endemicity. Am J Epidemiol 1988; 127: 1272-1281.

Gilman RH, Marquis GS, Miranda E et al. Rapid reinfection by Giardia lamblia after treatment in a hyperendemic Third World community. Lancet 1988; 1: 343-345.

Rousham EK. Perceptions and treatment of intestinal worms in rural Bangladesh: local differences in knowledge and behaviour. Soc Sci Med 1994; 39: 1063-1068.

Muller M, Sanchez RM, Suswillo RR. Evaluation of a sanitation programme using eggs of Ascaris lumbricoides in household yard soils as indicators. J Trop Med Hyg 1989; 92: 10-16.

Albert MJ, Faruque AS, Faruque SM et al. Case-control study of enteropathogens associated with childhood diarrhea in Dhaka, Bangladesh. J Clin Microbiol 1999; 37: 3458-3464.

Huilan S, Zhen LG, Mathan MM et al. Etiology of acute diarrhea among children in developing countries: a multicentre study in five countries. Bull World Health Organ 1991; 69: 549-555.

Loening WE, Coovadia YM, van den Ende J. Aetiological factors of infantile diarrhea: a community-based study. Ann Trop Paediatr 1989; 9: 248-255.

Was this article helpful?

0 0
Living Gluten Free

Living Gluten Free

A beginners guide that will reveal how living "G" free can help you lose weight today! This is not a fad diet, or short term weight loss program that sometimes makes you worse off than before you started. This is a necessity for some people and is prescribed to 1 out of every 100 people on earth by doctors and health professionals.

Get My Free Ebook


Post a comment